Trademark: 97620822
Word
PHAGESELECT
Status Date
Wednesday, December 6, 2023
Filing Date
Wednesday, October 5, 2022
Published for Opposition
Tuesday, April 18, 2023
40 Custom manufacture of pharmaceuticals in the nature of bacteriophage therapeutics for others
9 Computer software system comprised of downloadable computer software for identifying precision therapy for treatment of bacterial infections
5 human, animal, plant and microorganism biological preparations for disease modeling and personalized medicine to prevent or treat bacterial infectious diseases; bactericides, namely, biological preparations to treat bacterial infections and bacterial contamination in the field of medicine; diagnostic kits comprising medical diagnostic reagents for testing bacteria sensitivity
1 diagnostic reagents for clinical and medical laboratory use; diagnostic kits comprising diagnostic reagents for testing bacteria sensitivity, except for medical or veterinary use; human, animal, plant and microorganism biological preparations for use in industry and science, namely, for use in drug development; Biological preparations for use in industry and science, namely, for treating bacterial contamination in the fields of farming and food preparation; Biological preparations for use in industry and science, namely, for treating bacterial contamination in the industrial and food preparation fields
44 medical testing for diagnostic or treatment purposes in the field of personalized medicine; health care services, namely, providing a database in the field of personalized medicine and featuring inputting and collection of data and information all for treatment and diagnostic purposes; medical testing for diagnostic or treatment purposes, namely, providing medical diagnostic assays and diagnostic and prognostic testing for treatment purposes of bacteria infections and the analysis, evaluation, and reporting of those test results to help healthcare professionals determine a patient's clinical diagnosis, the effectiveness of patient treatments, and to revise future treatments accordingly; medical services; medical consulting services in the field of medical diagnostic and prognostic testing; medical services in the nature of medical analysis services for diagnostic and prognostic testing and treatment purposes; medical analysis services relating to the diagnosis and treatment of a person; medical testing and medical diagnostic services for diagnostic or treatment purposes, in particular performing tests using diagnostic assays
42 new product research and development in the fields of personalized medicine and diagnostics; data mining of healthcare and genetic information in the field of precision medicine and personalized medicine; scientific study and research in the fields of biochemistry, disease, personalized medicine, personalized therapeutics, and pharmaceuticals; medical laboratory services and scientific laboratory services in the nature of clinical and medical laboratory services for medical research purposes in the fields of disease diagnostics and personalized medicine; pharmaceutical drug research and development; custom biochemical assay development; pharmaceutical drug discovery and development services; providing laboratory research services in the field of medical diagnostics and personalized medicine; medical research services; biotechnology research; providing medical and scientific research information in the field of clinical trials; new product research and development of vaccines and therapeutics; providing temporary use of online non-downloadable computer software application in the field of personalized medicine to provide medical and diagnostic services involving bacterial infections; medical research, namely, providing medical diagnostic assays and diagnostic and prognostic testing for medical research purposes of bacterial infections and the analysis, evaluation and reporting of those test results to help healthcare professionals for research purposes; development of new technology for others in the field of biotechnology; laboratory research in the field of genomic sequencing; research and development in the pharmaceutical and biotechnology fields; research development, engineering and testing services in the fields of bacteria and viruses; laboratory research in the field of infectious diseases; medical and scientific research in the field of immunotherapy; medical laboratory services; laboratory research services in the field of microbiological laboratory testing of bacteria for research purposes and technical consultation relating thereto; scientific and medical research, in particular, design and development of diagnostic assays; medical laboratory services in the nature of testing services for diagnostic purposes in the fields of disease diagnostics and personalized medicine; medical laboratory services in the nature of microbiological laboratory testing of bacteria for diagnostic and medical purposes, and technical consultation thereto
The mark consists of the word PHAGESELECT to the right of a hexagon design made up of seven individual hexagons and lines connecting all but one of the seven hexagons.
PHAGE SELECT
Color is not claimed as a feature of the mark.
Dec 8, 2023
Notice Of Approval Of Extension Request E-Mailed
Dec 6, 2023
Sou Extension 1 Granted
Dec 6, 2023
Sou Extension 1 Filed
Dec 6, 2023
Sou Teas Extension Received
Jun 13, 2023
Noa E-Mailed - Sou Required From Applicant
Apr 18, 2023
Official Gazette Publication Confirmation E-Mailed
Apr 18, 2023
Published For Opposition
Apr 4, 2023
Applicant/Correspondence Changes (Non-Responsive) Entered
Apr 4, 2023
Teas Change Of Correspondence Received
Apr 4, 2023
Attorney/Dom.Rep.Revoked And/Or Appointed
Apr 4, 2023
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Apr 4, 2023
Teas Change Of Owner Address Received
Mar 29, 2023
Notification Of Notice Of Publication E-Mailed
Mar 14, 2023
Approved For Pub - Principal Register
Mar 14, 2023
Examiner's Amendment Entered
Mar 14, 2023
Notification Of Examiners Amendment E-Mailed
Mar 14, 2023
Examiners Amendment E-Mailed
Mar 14, 2023
Examiners Amendment -Written
Mar 6, 2023
Assigned To Examiner
Oct 26, 2022
Notice Of Design Search Code E-Mailed
Oct 25, 2022
New Application Office Supplied Data Entered
Oct 8, 2022
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
